Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

2719 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Serclutamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5853-1mg

IchorBio
1 mg Login
Compare
Serclutamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5853-25mg

IchorBio
25 mg Login
Compare
Serclutamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5853-50mg

IchorBio
50 mg Login
Compare
Serclutamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5853-5mg

IchorBio
5 mg Login
Compare
Seribantumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5854-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Seribantumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5854-1mg

IchorBio
1 mg Login
Compare
Seribantumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5854-25mg

IchorBio
25 mg Login
Compare
Seribantumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5854-50mg

IchorBio
50 mg Login
Compare
Seribantumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5854-5mg

IchorBio
5 mg Login
Compare
Sibrotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5860-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Sibrotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5860-1mg

IchorBio
1 mg Login
Compare
Sibrotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5860-25mg

IchorBio
25 mg Login
Compare
Sibrotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5860-50mg

IchorBio
50 mg Login
Compare
Sibrotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5860-5mg

IchorBio
5 mg Login
Compare
Sigvotatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5862-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Sigvotatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5862-1mg

IchorBio
1 mg Login
Compare
Sigvotatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5862-25mg

IchorBio
25 mg Login
Compare
Sigvotatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5862-50mg

IchorBio
50 mg Login
Compare
Sigvotatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5862-5mg

IchorBio
5 mg Login
Compare
Sirtratumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5868-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Sirtratumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5868-1mg

IchorBio
1 mg Login
Compare
Sirtratumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5868-25mg

IchorBio
25 mg Login
Compare
Sirtratumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5868-50mg

IchorBio
50 mg Login
Compare
Sirtratumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5868-5mg

IchorBio
5 mg Login
Compare
Sirtratumab Vedotin Biosimilar -­ Research Grade Hu FA CHO cells ICH5868V-0.1mg

IchorBio
0.1 mg Login
Compare
Name Price
Serclutamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Serclutamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Serclutamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Serclutamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Seribantumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Seribantumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Seribantumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Seribantumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Seribantumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Sibrotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Sibrotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Sibrotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Sibrotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Sibrotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Sigvotatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Sigvotatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Sigvotatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Sigvotatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Sigvotatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Sirtratumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Sirtratumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Sirtratumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Sirtratumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Sirtratumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Sirtratumab Vedotin Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 0.1 mg
Available

2719 Item(s)

per page